Keros Therapeutics (KROS.BOATS) Q1 2026 Earnings

4MarConfirmed
Q4 2025
Q1 2026
-1.14
-0.82
-0.5
-0.18

Details

Expected EPS
-0.697129
Actual EPS
-0.86
Surprise EPS
-0.16
Surprise Percent
+23.36%

Description

Keros Therapeutics (KROS.BOATS) has reported earnings of -0.86 per share for Q1 2026.

0 Comments

Share your thoughts